Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the general population.
DelveInsight’s “Chronic Neuropathic Pain Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Chronic Neuropathic Pain, historical and forecasted epidemiology as well as the Chronic Neuropathic Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Chronic Neuropathic Pain Market:
Request for a Sample Page: https://www.delveinsight.com/sample-request/chronic-neuropathic-pain-market
Chronic Neuropathic Pain Market Report Highlights:
Central Neuropathic Pain results include multiple sclerosis (MS), spinal cord injury (SCI), central post stroke pain, and Parkinson disease.
Neuropathic pain is usually caused by chronic, progressive nerve disease, and it can also occur as the result of injury or infection. Chronic neuropathic pain, can flare up at any time without an obvious pain-inducing event or factor. Acute neuropathic pain which is uncommon, can occur as well.
Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the ageing global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy. Neuropathic pain may result from disorders of the peripheral nervous system or the central nervous system (brain and spinal cord). Thus, neuropathic pain may be divided into peripheral neuropathic pain, central neuropathic pain, or mixed (peripheral and central) neuropathic pain.
Key Chronic Neuropathic Pain Companies covered:
Chronic Neuropathic Pain Drugs covered:
Table of Contents:
1. Key Insights
2. Executive Summary of Hemophilia B
3. Competitive Intelligence Analysis for Hemophilia B
4. Hemophilia B: Market Overview at a Glance
5. Hemophilia B: Disease Background and Overview
6. Patient Journey
7. Hemophilia B Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Hemophilia B Treatment
11. Marketed Products
12. Emerging Therapies
13. Hemophilia B: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Hemophilia B
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market